These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26462805)

  • 1. PPARγ Regulation in Hypertension and Metabolic Syndrome.
    Stump M; Mukohda M; Hu C; Sigmund CD
    Curr Hypertens Rep; 2015 Dec; 17(12):89. PubMed ID: 26462805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.
    Ketsawatsomkron P; Keen HL; Davis DR; Lu KT; Stump M; De Silva TM; Hilzendeger AM; Grobe JL; Faraci FM; Sigmund CD
    Hypertension; 2016 Jan; 67(1):214-22. PubMed ID: 26597823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor.
    Dobrian AD
    Vascul Pharmacol; 2006 Jul; 45(1):36-45. PubMed ID: 16716756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
    Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can PPARgamma agonists have a role in the management of obesity-related hypertension?
    Chetty VT; Sharma AM
    Vascul Pharmacol; 2006 Jul; 45(1):46-53. PubMed ID: 16713364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of ARB in metabolic syndrome.
    Yamada S
    Curr Vasc Pharmacol; 2011 Mar; 9(2):158-61. PubMed ID: 21143168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.
    Tseng V; Sutliff RL; Hart CM
    Antioxid Redox Signal; 2019 Oct; 31(12):874-897. PubMed ID: 30582337
    [No Abstract]   [Full Text] [Related]  

  • 8. Norbixin, an apocarotenoid derivative activates PPARγ in cardiometabolic syndrome: Validation by in silico and in vivo experimental assessment.
    A R; Agrawal N; Kumar H; Nath V; Kumar V
    Life Sci; 2018 Sep; 209():69-77. PubMed ID: 30076922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ and RhoBTB1 in hypertension.
    Fang S; Sigmund CD
    Curr Opin Nephrol Hypertens; 2020 Mar; 29(2):161-170. PubMed ID: 31789920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.
    Bloch M; Prock A; Paonessa F; Benz V; Bähr IN; Herbst L; Witt H; Kappert K; Spranger J; Stawowy P; Unger T; Fusco A; Sedding D; Brunetti A; Foryst-Ludwig A; Kintscher U
    Circ Res; 2012 Feb; 110(3):394-405. PubMed ID: 22207709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of peroxisome proliferator-activated receptor gamma in blood pressure regulation.
    Hamblin M; Chang L; Zhang J; Chen YE
    Curr Hypertens Rep; 2009 Aug; 11(4):239-45. PubMed ID: 19602323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.
    Cai W; Yang T; Liu H; Han L; Zhang K; Hu X; Zhang X; Yin KJ; Gao Y; Bennett MVL; Leak RK; Chen J
    Prog Neurobiol; 2018; 163-164():27-58. PubMed ID: 29032144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of peroxisome proliferator-activated receptor γ and δ in vascular diseases.
    Cheang WS; Fang X; Tian XY
    Circ J; 2013; 77(11):2664-71. PubMed ID: 24107399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of PPARγ, a transcription factor in cardiovascular disease].
    Mukohda M
    Nihon Yakurigaku Zasshi; 2019; 154(2):56-60. PubMed ID: 31406043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.
    Ketsawatsomkron P; Sigmund CD
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):123-30. PubMed ID: 25587903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
    Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP.
    Hashimoto R; Umemoto S; Guo F; Umeji K; Itoh S; Kishi H; Kobayashi S; Matsuzaki M
    J Atheroscler Thromb; 2010 Aug; 17(8):785-95. PubMed ID: 20460829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
    Bai Y; Zheng J; Yuan X; Jiao S; Feng C; Du Y; Liu H; Zheng L
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30463189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity.
    Li P; Song Y; Zan W; Qin L; Han S; Jiang B; Dou H; Shao C; Gong Y
    Diabetes; 2017 Feb; 66(2):300-313. PubMed ID: 27899484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
    Wang Q; Imam MU; Yida Z; Wang F
    Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.